Skip to main content

Table 4 Odds ratios of having prescription drugs for males, compared to females, after adjustment for age, multi-morbidity and relevant prescription drug in univariate analyses (Model 2)

From: Can gender difference in prescription drug use be explained by gender-related morbidity?: a study on a Swedish population during 2006

Prescription drug excluded from the analysis OR (95% CI) P-value
NSAIDs 0.44 (0.43-0.45) <0.001
Buspirone 0.45 (0.45-0.46) <0.001
Coxibs 0.45 (0.45-0.46) <0.001
Inhalable corticosteroids 0.45 (0.45-0.46) <0.001
Ipratropium 0.45 (0.45-0.46) <0.001
Selective beta-2 stimulants 0.45 (0.44-0.46) <0.001
Antidepressants 0.46 (0.45-0.47) <0.001
Benzodiazepines 0.46 (0.45-0.46) <0.001
Benzodiazepine-related drugs 0.46 (0.45-0.47) <0.001
Derivatives of benzodiazepines 0.46 (0.45-0.46) <0.001
Hydroxyzine 0.46 (0.45-0.46) <0.001
Migraine drugs 0.46 (0.45-0.47) <0.001
Nitrofurantoin 0.46 (0.45-0.47) <0.001
Paracetamol 0.46 (0.45-0.47) <0.001
Propiomazine 0.46 (0.45-0.46) <0.001
Trimethoprim 0.46 (0.45-0.47) <0.001
Estrogens 0.47 (0.46-0.48) <0.001
Gestagens 0.47 (0.46-0.48) <0.001
Pivmecillinam 0.47 (0.46-0.48) <0.001
Thyroid hormones 0.47 (0.46-0.48) <0.001
Anti-conception drugs 0.65 (0.64-0.66) <0.001